Release of brain hexokinase 1 from mitochondria induced by amyloid aggregates of α-synuclein
محل انتشار: پانزدهمین همایش بیوشیمی فیزیک ایران
سال انتشار: 1397
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 377
نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
CBC15_037
تاریخ نمایه سازی: 29 خرداد 1398
چکیده مقاله:
Recent studies suggest that accumulation of alpha-synuclein amyloid aggregates on mitochondria is associated with Parkinson disease and other Lewy body disorders. Clearly, these amyloid aggregates disrupt mitochondrial function and initiate a pathophysiological cascade leading to neuronal degeneration. However, the molecular mechanism(s) of alpha-synuclein toxicity and its effect on mitochondria, in particular, remain elusive. Hexokinase 1 (HK 1) is a key glycolytic enzyme that plays important roles by reducing mitochondrial reactive oxygen species (ROS) generation and preventing apoptosis in neurons and other cell types .In this study, we have investigated the effect of alpha-synuclein amyloid intermediates on the release of HK1 from rat brain mitochondria. We found that alpha-synuclein amyloid intermediates, including oligomer, protofibril, and mature fibril, triggered HK 1 detachment from mitochondrial membrane in a dose-dependent manner. Moreover, a significant decrease in HK 1 activity was observed upon addition of alpha-synuclein aggregates. Based on obtained results, we suggest that inactivation and detachment of HK 1 from mitochondrial membrane by alpha-synuclein aggregates may play important roles in oxidative stress and neurodegeneration of Parkinson disease.
کلیدواژه ها:
نویسندگان
Ziba Dehghani
Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
Ali Akbar Saboury
Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
Ali Akbar Meratan
Department of Biological Sciences, Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, Iran